Salesforce, Inc. (NYSE:CRM) had its price target raised to $370.00 by Oppenheimer analyst Brian Schwartz ahead of Q2 earnings, maintaining an Outperform rating. Expectations are low, with softening business trends and limited near-term catalysts. Q2 earnings may not change opinions on CRM, with execution risks in the 2H of 2026.

Agentforce and Data Cloud remain investable themes for Salesforce, Inc. (NYSE:CRM), despite potential risks. While CRM has gained popularity with its AI-powered platform, other AI stocks may offer greater upside potential and less downside risk. Consider exploring undervalued AI stocks for better investment opportunities.

In conclusion, Oppenheimer lowered the PT to $315 on CRM due to multiple compression. Q2 earnings may not bring new opinions, with AI messaging and estimates likely unchanged post results. Despite risks, Agentforce and Data Cloud remain strong themes, with margin growth and discounted risks in multiples. No promotional or marketing content included.

Read more at Yahoo Finance: Oppenheimer Lifts Salesforce (CRM) Price Target to $370 Ahead of Earnings